Shares of Amylin Pharmaceuticals Inc. (Nasdaq: AMLN) fell nearly 4 percent Thursday ahead of a potential Food and Drug Administration decision on the company's long-acting version of a diabetes drug. Stock in the San Diego company has been extremely volatile, and earlier in the day hit a 52-week high.

As a Navy reservist who built careers in both the civilian and military worlds, Rear Adm. Russell Penniman sees how the two could learn from each other.

The number of homes in California that were in some stage of the foreclosure process dropped both month-to-month and year-to-year in February with one out of every 195 homes receiving some sort of foreclosure filing, according to a report on Wednesday.

California utilities won regulatory approval to buy tradable renewable-energy credits to comply with state clean-energy standards.

Trigild Inc., the San Diego-based troubled asset firm, continues to add to its distressed property portfolio, having been appointed receiver for the 24-story, 482,060-square-foot Viad Corporate Center office tower in Phoenix.